Liminatus Pharma, Inc. (LIMNW) stock
LIMNWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMN
$0.04+0.00 (0.00%)
Close on Oct 30, 2026Market cap $189.39MP/E –Yield –
Liminatus Pharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Liminatus Pharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$3.97M. For fiscal 2025 it was -$9.96M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.96M | – |
| FY2024 | Dec 31, 2024 | -$1.45M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$970.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.02M | – |
| Q4 FY2025 | Dec 31, 2025 | -$386.85K | – |
| Q3 FY2025 | Sep 30, 2025 | -$600.61K | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.82M | – |
| Q1 FY2025 | Mar 31, 2025 | -$159.39K | – |
| Q4 FY2024 | Dec 31, 2024 | -$140.66K | – |
| Q3 FY2024 | Sep 30, 2024 | -$206.12K | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.10M | – |
| Q1 FY2024 | Mar 31, 2024 | $0 | – |